Cytocom Inc. sell Midas
Start price
18.02.21
/
50%
€9.20
Target price
18.02.22
-
Performance (%)
-68.91%
End price
29.08.21
€2.86
Summary
This prediction ended on 29.08.21 with a price of €2.86. Midas correctly predicted massive losses of -68.91% for Cytocom Inc.. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytocom Inc. | - | - | - | - |
| iShares Core DAX® | 1.917% | 1.088% | 17.187% | 65.270% |
| iShares Nasdaq 100 | 0.911% | 1.674% | 7.930% | 101.983% |
| iShares Nikkei 225® | 0.833% | -1.712% | 12.100% | 44.368% |
| iShares S&P 500 | 0.242% | 1.258% | 3.167% | 62.336% |
Comments by Midas for this prediction
In the thread Cytocom Inc. diskutieren
Sell Cleveland Biolabs